Parasite treatment-focused pharmaceutical company ParaPRO is introducing Natroba (spinosad topical suspension, 0.9%) — the first new drug for scabies approved by the Food and Drug Administration in ...
MAGNOLIA, Texas — Pernix Therapeutics Holdings on Wednesday announced an exclusive co-promotion agreement with ParaPro for a medication to treat head lice. A new drug application for the prescription ...
focused on innovative treatments for human ectoparasites, introduced thought leader ai – a pioneering medical education platform that enables healthcare practitioners to engage 'live' with leading ...
CARMEL, Ind.--(BUSINESS WIRE)--ParaPRO LLC today announced that it has received a $2.1 million grant from Indiana’s 21st Century Research and Technology Fund. The grant will help ParaPRO finance the ...
The approval was based on data from 2 multicenter, randomized, double-blind, vehicle-controlled phase 3 trials. The Food and Drug Administration (FDA) has approved Natroba TM (spinosad) topical ...
MISSISSAUGA, ON, July 29, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") announces the signing of a definitive asset purchase agreement with ParaPRO LLC ...
Natroba™ does not require painstaking nit combing and for most patients is effective in one 10-minute application. Product demonstrated superior efficacy in Phase III trials vs. permethrin ...
Thought Leader AI Enables Prescribers to Transcend Boundaries of Space and Time to Speak "Live" with Leading Medical Experts CARMEL, Ind., Feb. 6, 2023 /PRNewswire/ -- ParaPRO, a specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results